A description of the first Candida auris-colonized individuals in New York State, 2016-2017
| Autor: | Karen Southwick, Belinda Ostrowsky, Jane Greenko, Eleanor Adams, Emily Lutterloh, Ronald Jean Denis, Rutvik Patel, Richard Erazo, Raphael Fernandez, Coralie Bucher, Monica Quinn, Crystal Green, Sudha Chaturvedi, Lynn Leach, YanChun Zhu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pediatrics
medicine.medical_specialty Antifungal Agents Epidemiology New York Article medicine Infection control Humans Hospital patients Feeding tube Aged Candida Transmission (medicine) business.industry Health Policy Public Health Environmental and Occupational Health Candida auris United States Hospitalization Infectious Diseases Contact precautions Positive culture Nursing homes business |
| Zdroj: | Am J Infect Control |
| ISSN: | 1527-3296 |
| Popis: | BACKGROUND Candida auris (C. auris), an emerging multi-drug resistant fungus, was first detected in New York State (NYS) in 2016. A person can be colonized with C. auris for months, contributing to environmental surface contamination within healthcare facilities (HCF) and increasing the likelihood of transmission. We describe characteristics of C. auris-colonized individuals (“surveillance cases”) in NYS HCFs to help target infection prevention recommendations. METHODS NYSDOH investigated all individuals with suspected or confirmed C. auris and conducted case finding for colonized individuals in HCFs. Specimens were tested for C. auris by polymerase chain reaction and culture. Surveillance cases had positive C. auris cultures without evidence of clinical infection. Hospital patients and nursing home residents (“facility-based surveillance cases”) were included in the analysis of demographic and clinical data. RESULTS Between 10/5/2016 and 11/7/2017, 114 facility-based surveillance cases were identified. The median age was 74 years (range 23-100 years). Facility-based surveillance cases had a median of three HCF admissions in 90 days before first positive culture (range 0-8). Ninety-three percent were from facilities in Brooklyn or Queens. Fifty-four percent had diabetes. During the week before first positive culture, 81% received mechanical ventilation, 80% had tracheostomy, and 70% had a percutaneous feeding tube. Thirty-four percent had no prior indications for Contact Precautions at time of first positive culture. To date only 9% had serial negative C. auris surveillance cultures. Sixty-two percent were known to be deceased. CONCLUSIONS NYSDOH identified many previously-unrecognized C. auris-colonized individuals in HCFs. They had medical comorbidities requiring invasive care and moved between multiple HCFs before their C. auris identification. HCFs should consider C. auris in their risk assessments and have a high index of suspicion for C. auris colonization among patients who have these characteristics. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect